Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Short-Term Debt repayments (2021)

Historic Short-Term Debt repayments for Amphastar Pharmaceuticals (AMPH) over the last 3 years, with Q3 2021 value amounting to $387000.0.

  • Amphastar Pharmaceuticals' Short-Term Debt repayments changed N/A to $387000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was $387000.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2021, which is N/A changed from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Short-Term Debt repayments stood at $387000.0 for Q3 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Short-Term Debt repayments peaked at $387000.0 during Q3 2021, and registered a low of $387000.0 during Q3 2021.